Login / Signup
Spinal muscular atrophy: Should we prescribe approved drugs to cohorts of patients in which they are unproven?
Lorenzo Fontanelli
Giulia Di Rauso
Gabriele Bellini
Published in:
European journal of neurology (2023)
Keyphrases
</>
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
patient reported
drug administration